Supply of Lidocaine Hydrochloride and Epinephrine Injection

The contract seeks the supply of Lidocaine Hydrochloride and Epinephrine Injection, USP in cartridge form, requiring full compliance with FDA current Good Manufacturing Practices, National Drug Code requirements, and applicable medical labeling standards. The product must meet exacting pharmaceutical and regulatory criteria to ensure safety, efficacy, and consistency for medical use under Department of Defense contracts. All deliveries are to be performed at the designated location in Suffolk, Virginia, with the ZIP code 23435-5000 serving as the official place of performance. This is a subcontract under NAICS code 325412, classified under the Medical Supply Chain Pharmaceutical FSA, and was posted on July 28, 2026, with a response deadline of August 3, 2026. The solicitation is managed through the DLA BSM system, under the reference SPE2DP26T4345, and is intended for qualified manufacturers or suppliers capable of delivering U.S. pharmacopeia-compliant injectable products to federal medical supply channels. There is no set-aside designation specified, meaning the opportunity is open to all eligible entities without restriction based on size or ownership status.